# Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II)

Study · id `cardio:ct-nct07343076` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07343076](<https://clinicaltrials.gov/study/NCT07343076>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07343076

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1904 participants.

## Technical summary

Registry record NCT07343076. Randomized; single masking; primary purpose treatment. Start 2026-02-28 (anticipated); primary completion 2029-02-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1904 participants (planned count; ClinicalTrials.gov record NCT07343076, source copy `cardio:ctgov-nct07343076-2026-01-30`, retrieved 2026-10-26)
- Planned start: 2026-02-28 (anticipated) (ClinicalTrials.gov record NCT07343076, source copy `cardio:ctgov-nct07343076-2026-01-30`, retrieved 2026-10-26)
- Primary completion: 2029-02-28 (anticipated) (ClinicalTrials.gov record NCT07343076, source copy `cardio:ctgov-nct07343076-2026-01-30`, retrieved 2026-10-26)
- Completion: 2031-02-28 (anticipated) (ClinicalTrials.gov record NCT07343076, source copy `cardio:ctgov-nct07343076-2026-01-30`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07343076-2026-01-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II)
- Condition: NSTEMI
- Condition: NSTEMI - Non-ST Segment Elevation MI
- Condition: Non-ST-elevation Acute Coronary Syndrome
- Condition: NSTE-ACS (NSTEMI and UA)
- Intervention (Device): Immediate Complete Revascularization
- Intervention (Device): Staged Complete Revascularization
- Lead sponsor: RenJi Hospital
- Lead sponsor class: OTHER
- Collaborator: People's Hospital of Xinjiang Uygur Autonomous Region
- Collaborator class: OTHER
- Collaborator: LanZhou University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry lists this organization as the lead sponsor: RenJi Hospital (`cardio:org-renji-hospital`)
- Registry lists this organization as a collaborator: People's Hospital of Xinjiang Uygur Autonomous Region (`cardio:org-people-s-hospital-of-xinjiang-uygur-autonomous-region`)
- Registry lists this organization as a collaborator: LanZhou University (`cardio:org-lanzhou-university`)

## Provenance

Content hash: c1c77b4caaa33255658e0983a981196dd884accea967ffd3e365425de39ad1fd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
